Related Experiment Video
Updated: Jun 8, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Nonadherence to medication in hypothyroidism: a case report.
Rajeev C Kandukuri1, Mehnaz A Khan, Stephen M Soltys
1Department of Psychiatry, Southern Illinois University School of Medicine, Springfield, Illinois, USA.
Primary Care Companion to the Journal of Clinical Psychiatry
|October 15, 2010
Summary
Nonadherence to hypothyroidism medication can cause complications. Improving patient outcomes requires addressing both biological and psychosocial factors, emphasizing the physician-patient relationship beyond just medication.
Area of Science:
- Endocrinology
- Internal Medicine
- Patient Adherence Research
Background:
- Hypothyroidism requires consistent medication adherence for effective management.
- Nonadherence presents significant challenges in achieving optimal patient outcomes.
- Treatment complexity involves biological and psychosocial dimensions.
Purpose of the Study:
- To review consequences of nonadherence to hypothyroidism medication.
- To examine the multifaceted nature of hypothyroidism treatment.
- To highlight the importance of psychosocial factors in treatment success.
Main Methods:
- Case report review.
- Analysis of biologic and psychosocial aspects of hypothyroidism.
- Examination of physician-patient relationship dynamics.
Main Results:
- Nonadherence leads to adverse health consequences.
- Medication adherence alone is insufficient for optimal outcomes.
- Psychosocial factors significantly impact treatment efficacy.
Conclusions:
- Effective hypothyroidism management necessitates addressing psychosocial factors.
- A strong physician-patient relationship is crucial for improving adherence.
- Holistic treatment strategies are essential for managing hypothyroidism.
Related Concept Videos
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...